What does 95.2% purity on a C18 column actually tell me about a survodutide vial?

Accepted answer

It tells you 95.2 per cent of the integrated area came off a C18 column where survodutide comes off, and the remaining 4.8 per cent did not. That is an area statement at one wavelength, not a mass statement about the vial: 4.8 per cent of area is only 4.8 per cent of mass if every impurity absorbs exactly as strongly as the parent, which none of them do. It also says nothing about how many milligrams are in the glass — water, counter-ion and a short fill are all invisible to it. What a C18 column does add is a constraint on what could be hiding: a column that retains by hydrophobicity separates deletion sequences well and separates isomers of identical hydrophobicity not at all.

The limit of this technique for these molecules is reaching a point where small improvements require proportionally large investments in method development.

Proline-rich sequences are particularly problematic because the isomerisation kinetics are in the same timescale as the separation, leading to split or broadened peaks at low temperature.

Trifluoroacetic acid at 0.1 per cent is the standard ion-pairing agent because it suppresses tailing by neutralising the basic residues, but it also suppresses mass spectrometry signal.

The resolving power of a separation is quantified by the resolution parameter R, defined from the heights and widths of adjacent peaks, and pharmacopoeial methods typically demand R greater than 1.5 for a method to be considered validated.

If two labs give different numbers, the method difference is the first hypothesis, not lab quality.